ライフサイエンスコーパス: shortness

1 afluoroborate, with the record linearity and shortness (2.07 angstrom) of the NH...pai-centroid bond,

2 Read shortness and sequencing errors pose a major challenge t

3 hydrogen bonds, despite their extraordinary shortness (as short as 2.0 A).

4 Telomere shortness in human beings is a prognostic marker of agei

5 Telomere shortness in human beings is emerging as a prognostic ma

6 lt, the previous record of the hydrogen bond shortness (N...N = 2.524 A) has been surpassed in favor

7 shape caused by force toward the PM and with shortness of active zone material macromolecules linking

8 5; p<0.1), sputum (3.15, 1.39-7.13; p<0.05), shortness of breath (1.86, 0.97-3.57; p<0.1), and wheeze

9 %]), cardiac dysfunction (114 of 210 [54%]), shortness of breath (102 of 198 [52%]), and/or diarrhea

10 ords among patients with the U09.9 code were shortness of breath (130 [37.1%]), fatigue or exhaustion

11 dizziness (21%), nausea/vomiting (26%), and shortness of breath (14%).

12 (47.1%) participants, with fatigue (21.2%), shortness of breath (14.5%) and forgetfulness (9.1%) the

13 ratio 2.07 [95% CI 1.41-3.05]), waking with shortness of breath (2.32 [1.25-4.34]), and asthma attac

14 mplain of fatigue (54% v 20%; P = .0002) and shortness of breath (22% v 8%; P = .02).

15 s reported at 3 months were fatigue (50.3%), shortness of breath (23.4%), confusion or lack of concen

16 ness (247 [49.3%]; 95% CI, 44.9%-53.7%), and shortness of breath (232 [46.3%]; 95% CI, 41.9%-50.7%).

17 symptom was palpitation (85.7%) followed by shortness of breath (25%).

18 [77.8%] vs 39 of 40 [97.5%]; ASD, 0.63) and shortness of breath (3 of 9 [33.3%] vs 23 of 40 [57.5%];

19 th respiratory symptoms such as cough (40%), shortness of breath (34%), hemoptysis (10%), or metastas

20 igue (70.7%), sleep disturbance (47.8%), and shortness of breath (42.1%).

21 re affected by vocal fold weakness (55%) and shortness of breath (55%), and 11% required ventilatory

22 These included cough (64%), shortness of breath (56%), and temperature elevation (33

23 The most frequent acute symptoms were shortness of breath (57.9%), weakness (54.8%), and fatig

24 m-based descriptions of chest pain (34%) and shortness of breath (6.5%) and the condition-based diagn

25 The most common presenting symptoms were shortness of breath (63.5%), fever (52.4%), and cough (4

26 le and/or irritation (92.1%), cough (78.5%), shortness of breath (72.5%), and pain on deep inspiratio

27 0%), chest tightness (93%), cough (80%), and shortness of breath (73%).

28 The most common LC symptom was shortness of breath (80%), and 27% of participants were

29 solute standardized difference [ASD], 0.30), shortness of breath (9 of 9 [100%] vs 7 of 23 [30.4%]; A

30 rrelated with increasing fatigue, increasing shortness of breath (both, r = -0.35; P =.

31 01), and limitation in desired activities by shortness of breath (difference, 2.8; 95% CI, 1.3-4.3; P

32 CI, 1.6-4.8; P < .001), sleep limitation by shortness of breath (difference, 3.0; 95% CI, 1.6-4.4; P

33 with each subject waking and complaining of shortness of breath (mean time to arousal, 115 s; range,

34 verweight/obese children more often reported shortness of breath (odds ratio = 11.8; 95% CI, 1.41-98.

35 On multivariable analysis, shortness of breath (odds ratio [OR], 0.008; p = 0.072),

36 .93), anxiety (OR, 1.57; 95% CI, 1.30-1.89), shortness of breath (OR, 1.38; 95% CI, 1.16-1.61), femal

37 epression (OR, 1.66; 95% CI, 1.20-2.31), and shortness of breath (OR, 1.65; 95% CI, 1.18-2.31) and ea

38 CI, 1.3 to 2.2), attacks of wheezing causing shortness of breath (OR, 1.6; 95% CI, 1.2 to 2.1) or awa

39 % confidence interval [95% CI], 1.15, 4.47), shortness of breath (OR, 2.33; 95% CI, 1.12, 5.06), and

40 CI; 1.3 to 4.3), attacks of wheezing causing shortness of breath (OR, 2.4; 95% CI, 1.3 to 4.4) or awa

41 Fever (OR, 1.66 [95% CI, 1.41-1.96]), shortness of breath (OR, 2.52 [95% CI, 2.00-3.16]), tach

42 ell as male sex (P = .025), wheezing causing shortness of breath (P = .002), and ACS at less than 4 y

43 in the relative risks for severe wheeze with shortness of breath (relative risk 0.44 [95% CI 0.20-1.0

44 95% confidence intervals [CIs] 1.41, 2.10), shortness of breath (RR 2.60, 95% CIs 1.96, 3.44), memor

45 s of estrogen treatment (abdominal pain 60%, shortness of breath 40%, or both 35%).

46 % confidence interval (CI): 1.11, 1.21]} and shortness of breath [OR=1.61 per 5mug/m(3) (95% CI: 1.45

47 - to 1.4-fold more likely to report cough or shortness of breath and 1.8-fold more likely to report c

48 The association between shortness of breath and a 5-mug/m(3) increment in PM2.5

49 moderate to severe anxiety, depression, and shortness of breath and an increasing t-ESAS score after

50 tween prevalence of self-reported wheeze and shortness of breath and annual mean particulate matter w

51 Greater shortness of breath and beta-agonist use appears to be p

52 rgency department in December with worsening shortness of breath and chest heaviness for 1 week.

53 ed by age 5-6, and predominant symptoms were shortness of breath and chest tightness.

54 such abnormalities were more likely to have shortness of breath and chronic cough and reduced measur

55 d BV may contribute to exercise intolerance, shortness of breath and chronic fatigue, secondary to re

56 gency department of an outside hospital with shortness of breath and cough.

57 He was admitted to evaluate progressive shortness of breath and dry cough of 1-month duration.

58 Shortness of breath and fatigue were reported by virtual

59 ection, whose symptoms include fever, cough, shortness of breath and fatigue.

60 A 72-year-old man presented with progressive shortness of breath and increasing consolidation.

61 nter of UCSD Medical Center with significant shortness of breath and limitation of daily activities.

62 two adverse events of grade 2 or higher (n=1 shortness of breath and n=1 arthralgia) and none in the

63 homa is a medical condition characterised by shortness of breath and obscure chest pain, which may be

64 ss, headache and numbness), cardiopulmonary (shortness of breath and oedema), dermatological (pruritu

65 or wall myocardial infarction presented with shortness of breath and palpitations.

66 our averages) were associated with increased shortness of breath and rescue medication use.

67 resulting in right ventricular failure with shortness of breath and syncope.

68 bo, n=1), which was unrelated to study drug (shortness of breath and throat tightness after severe co

69 Early symptoms of shortness of breath and wheezing progressed over 2 wk to

70 y department of our hospital for progressive shortness of breath and worsening productive cough of 2

71 k of fatigue, sexual dysfunction, dysphagia, shortness of breath and/or hypotension, procedure-relate

72 Fluid retention and shortness of breath are its cardinal manifestations for

73 hite (odds ratio, 2.2; 1.1 to 4.3), reported shortness of breath as their chief symptom (odds ratio,

74 versus those without lesions), particularly "shortness of breath at night" (odds ratio (OR) = 2.8, 95

75 cirrhosis presented with a 2-week history of shortness of breath at rest, orthopnea, and lower extrem

76 of 54 patients newly diagnosed with episodic shortness of breath attributed to ILO were evenly random

77 Contacts who developed fever, cough, or shortness of breath became persons under investigation a

78 She is somewhat limited by the shortness of breath but maintains an Eastern Cooperative

79 ges in both patients, but angina or abnormal shortness of breath did not develop in either patient du

80 wenty-two (22%) of 98 patients complained of shortness of breath during everyday activities compared

81 -MB) and one of the following: chest pain or shortness of breath during the preceding 24 h or electro

82 (OR = 2.8, 95% CI: 1.2, 6.6) in smokers and "shortness of breath ever" (OR = 3.8, 95% CI: 0.7, 20.6)

83 Patients with symptoms of abdominal pain and shortness of breath had significantly increased hepatic

84 ver in 20 patients (87%), cough in 20 (87%), shortness of breath in 11 (48%), and gastrointestinal sy

85 linical features of MTX lung injury included shortness of breath in 27 patients (93.1%), which was pr

86 omatic, with cough reported in all patients, shortness of breath in 94%, and hemoptysis in 55%.

87 Reporting fever, cough, or shortness of breath in the last week during symptom scre

88 Reporting fever, cough, or shortness of breath in the last week during symptom scre

89 associated with the prevalence of wheeze and shortness of breath in this large study, with stronger a

90 atment was terminated prematurely because of shortness of breath in three patients in each group.

91 n unsuspected in patients with COPD, because shortness of breath is attributed to COPD.

92 en characterized by hypotension, nausea, and shortness of breath occurring within 30 minutes after ad

93 ion of microwave popcorn had higher rates of shortness of breath on exertion and skin problems that h

94 symptoms, defined as any reported wheezing, shortness of breath or dry nocturnal cough, were reporte

95 symptoms occurring most frequently included shortness of breath or dyspnea (26 studies; median frequ

96 atic and denied fevers, sweats, weight loss, shortness of breath or dyspnea on exertion, or cough.

97 Slight improvement in shortness of breath or fatigue was associated with signi

98 tion defined by meeting both criteria of (1) shortness of breath or hospitalization for shortness of

99 ere most strongly influenced by the risks of shortness of breath or hypotension, fatigue, and procedu

100 ) shortness of breath or hospitalization for shortness of breath or pneumonia and (2) oxygen saturati

101 76-year-old man consults you for increasing shortness of breath over the past two years and an incre

102 vel of asthma severity, whereas intensity of shortness of breath predicted HRQL at all levels of asth

103 change in University of California San Diego-Shortness of Breath Questionnaire (UCSD-SOBQ) score, cha

104 dyspnea (University of California, San Diego Shortness of Breath Questionnaire [UCSD SOBQ]), 6-minute

105 55] and University of California, San Diego, Shortness of Breath Questionnaire total score [r = 0.70]

106 s in the University of California, San Diego Shortness of Breath Questionnaire), health status (reduc

107 6D; the University of California, San Diego, Shortness of Breath Questionnaire; FVC; Dl(CO); and 6-mi

108 23, participants aged 21 years or older with shortness of breath recruited from 4 clinical sites unde

109 Some symptoms such as breathlessness and shortness of breath seem not to be evidence-based asthma

110 the emergency department with chest pain and shortness of breath shortly after a viral infection.

111 ngeal obstruction (ILO) presents as episodic shortness of breath that can range in severity and may g

112 report a range of symptoms from headaches to shortness of breath to taste and smell loss.

113 n exposures and the prevalence of wheeze and shortness of breath using harmonized baseline data from

114 rrelation (rg) with diabetes (rg = 0.25) and shortness of breath walking on level ground (rg = 0.28)

115 An increased risk of shortness of breath was also associated with the combina

116 Shortness of breath was also more common among nonhospit

117 Shortness of breath was higher on days 7-21, with a dip

118 Shortness of breath was more common among persons with a

119 Shortness of breath was the most common presenting sympt

120 Shortness of breath was the only symptom associated with

121 trial in which patients seen in the ED with shortness of breath were consented to have BNP levels dr

122 Fatigue and shortness of breath were significantly more common in pa

123 5-3.7) in men and 2.7 (2.3-3.1) in women for shortness of breath when walking upstairs; 4.5 (2.5-7.8)

124 He reports both mild shortness of breath with exertion and minimal chronic sw

125 c inflammatory condition defined by episodic shortness of breath with expiratory wheezing and cough,

126 igue, headache, fever, muscle or joint pain, shortness of breath) were the most important clinical pr

127 y symptoms (persistent or recurring cough or shortness of breath), 2) chronic bronchitis or emphysema

128 typical symptoms of covid-19 (cough, fever, shortness of breath), of whom only five were tested befo

129 atic with typical symptoms (fever, cough, or shortness of breath), symptomatic with only atypical sym

130 s, headache, loss of taste and/or smell, and shortness of breath).

131 tail bone, and one woman had chest pain and shortness of breath).

132 44%) were asymptomatic, but 8 (44%) reported shortness of breath, 7 (39%) reported cough, and 5 (28%)

133 r nausea, 57% for pain, 94% for appetite and shortness of breath, 87% for anxiety, 86% for depression

134 f LVP performed, cumulative volume from LVP, shortness of breath, abdominal distention, abdominal pai

135 imes the expected rates of chronic cough and shortness of breath, according to comparisons with the n

136 of 2020, all respiratory conditions, except shortness of breath, accounted for a smaller proportion

137 ce of obesity, absence of diabetes mellitus, shortness of breath, and a short delay between pain onse

138 Fever, chills, cough, shortness of breath, and abdominal or chest pain were de

139 r or more weeks after infection) of fatigue, shortness of breath, and cognitive dysfunction, as well

140 ypes, characterized by symptoms of wheezing, shortness of breath, and coughing due to airway hyperrea

141 uction characterised clinically by wheezing, shortness of breath, and coughing.

142 tion, which can lead to reduced oxygenation, shortness of breath, and death.

143 soon thereafter she had a headache, nausea, shortness of breath, and dizziness.

144 ith physical symptoms, such as palpitations, shortness of breath, and dizziness.

145 ymptoms, including severity of fever, cough, shortness of breath, and fatigue (rated on a 4-point sca

146 s included headache, fever, chills, myalgia, shortness of breath, and fatigue.

147 common cluster consisted of cough, fatigue, shortness of breath, and headache and was found in 308 (

148 Age, overall presence of symptoms, shortness of breath, and hypertension were found to be k

149 During March 2020, cough, shortness of breath, and influenza-like illness accounte

150 , worse ESAS-r scores (tiredness, wellbeing, shortness of breath, and pain), PHQ-9 scores (12.5 (6, 1

151 l distention, a 5-pound weight gain, nausea, shortness of breath, and reduced urinary frequency.

152 ort severe fatigue, orthostatic intolerance, shortness of breath, and reductions in exercise toleranc

153 or taste, thirst, chronic cough, chest pain, shortness of breath, and sleep apnea.

154 iated with ED/Hosp use, with pain, appetite, shortness of breath, and tiredness demonstrating the str

155 sease (a cough, a fever of 37.8 C or higher, shortness of breath, anosmia, or ageusia).

156 sthma (past 12 months), defined as: woken by shortness of breath, asthma attack, or asthma medication

157 rity of 6 PASC symptoms (fatigue, brain fog, shortness of breath, body aches, gastrointestinal sympto

158 th poor well-being, depression, anxiety, and shortness of breath, but not with other somatic symptoms

159 Patients frequently suffer from cough, shortness of breath, chest pain and pronounced fatigue a

160 viously experienced intermittent episodes of shortness of breath, chest pain, and palpitations with e

161 isode are similar, and both can present with shortness of breath, chest pain, cough, and wheezing.

162 uded fever in 13 patients (41%) and moderate shortness of breath, chest pain, or both in six (19%).

163 ealth status, including symptoms of fatigue, shortness of breath, chest pain, physical and social lim

164 piratory symptoms (wheeze, persistent cough, shortness of breath, chest tightness).

165 ts with acute asthma will exhibit increasing shortness of breath, chest tightness, coughing, and/or w

166 Adults were often afebrile and complained of shortness of breath, chills, and severe pain.

167 % of participants experienced some degree of shortness of breath, cough, difficulty breathing, appeti

168 The patient denied chest pain, shortness of breath, cough, or recent exposure to sick i

169 the chief complaints of dyspnea on exertion, shortness of breath, dysphagia, generalized weakness, an

170 Shortness of breath, dyspnea, or respiratory distress or

171 lds, wheeze frequency, activity disturbance, shortness of breath, exercise-related and aeroallergen-r

172 rdiopulmonary symptoms including chest pain, shortness of breath, fatigue, and autonomic manifestatio

173 Its symptoms, including shortness of breath, fatigue, and edema, can be frighten

174 Three (shortness of breath, fear of progression, and hair probl

175 Four (coughing, shortness of breath, fear of progression, and surgery-re

176 omposed of five multi-item scales (coughing, shortness of breath, fear of progression, hair problems,

177 Humans typically exhibit fever, cough, shortness of breath, gastrointestinal issues, and breath

178 Transient symptoms, such as shortness of breath, headache, and dizziness, were repor

179 characterized by similar symptoms (fatigue, shortness of breath, headache, sleep disturbance, forget

180 ood had similar occurrences of pneumothorax, shortness of breath, hemoptysis, nephrectomy, and death.

181 e or probable symptoms of opioid withdrawal (shortness of breath, hot flushes, fever and pain, small

182 The patient presented with shortness of breath, malaise, and cough that had develop

183 combinations, 5 MPM symptoms (pain, fatigue, shortness of breath, muscle weakness, coughing) were sel

184 Cough, fever, shortness of breath, myalgia, fatigue/weakness and heada

185 one qualifying symptom (fever 37.8 C, cough, shortness of breath, or anosmia or ageusia) more than 14

186 f symptoms (pain, disturbed sleep, distress, shortness of breath, or constipation) reached a predeter

187 n patients presenting with acute chest pain, shortness of breath, or syncope.

188 ry muscle function may result in symptoms of shortness of breath, reductions in vital capacity, and a

189 Thirst was moderately intense, and shortness of breath, scared, confusion, and pain were mo

190 second dose, she developed chest tightness, shortness of breath, tongue swelling, diffuse pruritic r

191 iables most predictive of CD: age, diabetes, shortness of breath, use of vasodilator stress, rest hea

192 g, persistent coughing and mucus production, shortness of breath, wheezing, and chest tightness.

193 and lung cells causing fever, dry cough, and shortness of breath.

194 sus non-systolic dysfunction presenting with shortness of breath.

195 st common symptoms are fever, dry cough, and shortness of breath.

196 , consistent in univariate analysis only for shortness of breath.

197 mild to moderate symptoms such as cough and shortness of breath.

198 production, airway hyperresponsiveness, and shortness of breath.

199 ocognitive impairment and dysautonomia), and shortness of breath.

200 ome recovered patients complain of continued shortness of breath.

201 s second profile was mediated by fatigue and shortness of breath.

202 differences in the incidence of wheezing or shortness of breath.

203 showed positive associations with wheeze and shortness of breath.

204 ic pulmonary infiltrates, chronic cough, and shortness of breath.

205 of epigastric and midsternal chest pain with shortness of breath.

206 year-old man presents with left leg pain and shortness of breath.

207 present, then the most common complaint was shortness of breath.

208 nal pain, nausea, bilious emesis, cough, and shortness of breath.

209 oms, including cough, sputum production, and shortness of breath.

210 des increased sputum purulence and worsening shortness of breath.

211 , wheeze, cough, tightness of the chest, and shortness of breath.

212 t of diastolic dysfunction and inappropriate shortness of breath.

213 c peptides in patients presenting with acute shortness of breath.

214 ardiac and noncardiac, presenting with acute shortness of breath.

215 erval 0.37-0.86), fatigue (0.75, 0.46-1.24), shortness of breath/dyspnoea (0.52, 0.28-0.93), breast s

216 1.44 [95% confidence interval: 1.22, 1.70]; shortness of breath: 1.32 [1.12, 1.56]; dry cough: 1.16

217 ars; 63% women; 17% smokers; 77% phlegm; 70% shortness of breath; 47% wheezing; 46% chest pain; 42% a

218 The most common symptoms were cough and shortness of breath; 50% of patients had fever on admiss

219 ce of chimpanzees to humans and the relative shortness of our evolutionary separation suggest that mo

220 The shortness of recent human facial skeletons is the evolut

221 The shortness of region 2 would leave little of the peptide

222 s of magnitude because of the sparseness and shortness of sequencing reads.

223 are assumed to be negligible because of the shortness of the excitation process.

224 singleton's location can be measured by the shortness of the reaction time in a visual search for si

225 ired-end sequencing allows circumventing the shortness of the reads produced by second generation seq

226 al biological and historical causes, such as shortness of time spans between divergences for evolutio

227 function (r=-0.87), vitality (r=-0.85), and shortness-of-breath (r=0.84) scales.

228 Health Survey questionnaire, an established shortness-of-breath scale, and the Minnesota Living with

229 trophic Cardiomyopathy Symptom Questionnaire Shortness-of-Breath subscore (HCMSQ-SoB).

230 al bond distances, we make use of the formal shortness ratio (FSR) for comparison of bond distances b